E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 12
14 / 12Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

NJPPP Manuscript Submission Form

Case Report
Online Published: 10 Aug 2017
 


High-dose cytarabine-associated cerebellar toxicity: A case report

Delcey Reachel Varghese, Dawnwin Joseph, Raghuveer Prabhu, Anila K N.


Cited By:3

Abstract
High-dose arabinoside cytarabine is used as an effective regimen for post-remission acute leukemia and refractory leukemia treatment. Most commonly used regimen is 3 g/m2 IV over 1-3 h q12 h for a total of 8-12 doses. Major toxic effects associated with cytarabine are related to bone marrow, gastrointestinal tract, and nervous system. Acute cerebellar toxicity with ataxia and dysarthria is well-known adverse effect during high-dose cytarabine therapy. This case report describes about a patient with acute myeloid leukemia on high-dose cytarabine who developed ataxia and left-sided nystagmus as cerebellar toxicity. These symptoms persisted till 2 days after the termination of high-dose cytarabine the gradually improved with steroids. Patient’s good response to methyl prednisolone illustrates immune-mediated mechanism of neurotoxicity.

Key words: High-dose Arabinoside Cytarabine; Acute Myeloid Leukemia; Neurotoxicity


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Delcey Reachel Varghese
Articles by Dawnwin Joseph
Articles by Raghuveer Prabhu
Articles by Anila K N
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Varghese DR, Joseph D, Prabhu R, N AK. High-dose cytarabine-associated cerebellar toxicity: A case report. Natl J Physiol Pharm Pharmacol. 2018; 8(1): 142-143. doi:10.5455/njppp.2018.8.0724818072017

Web Style

Varghese DR, Joseph D, Prabhu R, N AK. High-dose cytarabine-associated cerebellar toxicity: A case report. https://www.njppp.com/?mno=272003 [Access: January 17, 2025]. doi:10.5455/njppp.2018.8.0724818072017

AMA (American Medical Association) Style

Varghese DR, Joseph D, Prabhu R, N AK. High-dose cytarabine-associated cerebellar toxicity: A case report. Natl J Physiol Pharm Pharmacol. 2018; 8(1): 142-143. doi:10.5455/njppp.2018.8.0724818072017


Vancouver/ICMJE Style

Varghese DR, Joseph D, Prabhu R, N AK. High-dose cytarabine-associated cerebellar toxicity: A case report. Natl J Physiol Pharm Pharmacol. (2018), [cited January 17, 2025]; 8(1): 142-143. doi:10.5455/njppp.2018.8.0724818072017


Harvard Style

Varghese, D. R., Joseph, . D., Prabhu, . R. & N, . A. K. (2018) High-dose cytarabine-associated cerebellar toxicity: A case report. Natl J Physiol Pharm Pharmacol, 8 (1), 142-143. doi:10.5455/njppp.2018.8.0724818072017


Turabian Style

Varghese, Delcey Reachel, Dawnwin Joseph, Raghuveer Prabhu, and Anila K N. 2018. High-dose cytarabine-associated cerebellar toxicity: A case report. National Journal of Physiology, Pharmacy and Pharmacology, 8 (1), 142-143. doi:10.5455/njppp.2018.8.0724818072017


Chicago Style

Varghese, Delcey Reachel, Dawnwin Joseph, Raghuveer Prabhu, and Anila K N. "High-dose cytarabine-associated cerebellar toxicity: A case report." National Journal of Physiology, Pharmacy and Pharmacology 8 (2018), 142-143. doi:10.5455/njppp.2018.8.0724818072017


MLA (The Modern Language Association) Style

Varghese, Delcey Reachel, Dawnwin Joseph, Raghuveer Prabhu, and Anila K N. "High-dose cytarabine-associated cerebellar toxicity: A case report." National Journal of Physiology, Pharmacy and Pharmacology 8.1 (2018), 142-143. Print. doi:10.5455/njppp.2018.8.0724818072017


APA (American Psychological Association) Style

Varghese, D. R., Joseph, . D., Prabhu, . R. & N, . A. K. (2018) High-dose cytarabine-associated cerebellar toxicity: A case report. National Journal of Physiology, Pharmacy and Pharmacology, 8 (1), 142-143. doi:10.5455/njppp.2018.8.0724818072017


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

  National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

Eldaghayes Publisher

www.eldagpublisher.com 
 
All correspondence should be addressed to:
Prof. Ibrahim Eldaghayes
Editor-in-Chief
National Journal of Physiology, Pharmacy and Pharmacology
Email: ibrahim.eldaghayes@vetmed.edu.ly